Man Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.9M Buy
99,978
+69,069
+223% +$15.1M 0.04% 434
2025
Q1
$6.92M Buy
30,909
+14,547
+89% +$3.26M 0.02% 750
2024
Q4
$5.36M Sell
16,362
-7,046
-30% -$2.31M 0.01% 865
2024
Q3
$7.03M Sell
23,408
-180,847
-89% -$54.3M 0.02% 797
2024
Q2
$67.3M Buy
204,255
+178,428
+691% +$58.8M 0.17% 130
2024
Q1
$10.2M Sell
25,827
-123,831
-83% -$49M 0.03% 662
2023
Q4
$52.7M Buy
+149,658
New +$52.7M 0.15% 153
2023
Q3
Sell
-251,465
Closed -$96.2M 74
2023
Q2
$96.2M Buy
+251,465
New +$96.2M 0.3% 62
2023
Q1
Sell
-54,877
Closed -$12.9M 246
2022
Q4
$12.9M Sell
54,877
-23,486
-30% -$5.53M 0.05% 470
2022
Q3
$19.3M Buy
+78,363
New +$19.3M 0.09% 261
2022
Q2
Sell
-206,773
Closed -$84.9M 66
2022
Q1
$84.9M Buy
206,773
+35,092
+20% +$14.4M 0.3% 69
2021
Q4
$80.5M Buy
171,681
+130,413
+316% +$61.2M 0.26% 79
2021
Q3
$17.5M Buy
41,268
+15,759
+62% +$6.69M 0.06% 373
2021
Q2
$9.16M Sell
25,509
-161
-0.6% -$57.8K 0.03% 614
2021
Q1
$7.23M Buy
25,670
+3,239
+14% +$913K 0.03% 544
2020
Q4
$6.36M Sell
22,431
-31,923
-59% -$9.04M 0.03% 662
2020
Q3
$14.9M Buy
54,354
+8,739
+19% +$2.4M 0.06% 346
2020
Q2
$10.4M Sell
45,615
-19,411
-30% -$4.41M 0.05% 352
2020
Q1
$9.9M Buy
65,026
+2,656
+4% +$404K 0.06% 292
2019
Q4
$9.38M Buy
62,370
+15,300
+33% +$2.3M 0.03% 719
2019
Q3
$6.68M Sell
47,070
-30,454
-39% -$4.32M 0.02% 737
2019
Q2
$9.7M Buy
77,524
+23,604
+44% +$2.95M 0.04% 643
2019
Q1
$5.94M Buy
53,920
+6,343
+13% +$699K 0.02% 816
2018
Q4
$4.66M Sell
47,577
-74,725
-61% -$7.33M 0.02% 798
2018
Q3
$15.1M Buy
122,302
+9,501
+8% +$1.17M 0.06% 427
2018
Q2
$11.2M Buy
112,801
+56,133
+99% +$5.57M 0.05% 518
2018
Q1
$5M Buy
+56,668
New +$5M 0.02% 829